Q1 2017 13F Holders as of 3/31/2017
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
4
-
Total 13F shares, excl. options
-
174K
-
Shares change
-
+1.8K
-
Total reported value, excl. options
-
$82K
-
Value change
-
-$503
-
Number of buys
-
1
-
Number of sells
-
-2
-
Price
-
$0.47
Significant Holders of IGC Pharma, Inc. - COM NEW (IGC) as of Q1 2017
4 filings reported holding IGC - IGC Pharma, Inc. - COM NEW as of Q1 2017.
IGC Pharma, Inc. - COM NEW (IGC) has 4 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 174K shares
.
Largest 7 shareholders include CITADEL ADVISORS LLC (91.5K shares), PANAGORA ASSET MANAGEMENT INC (49.2K shares), KCG HOLDINGS, INC. (29.8K shares), UBS Group AG (3.89K shares), Creative Planning (65K shares), LADENBURG THALMANN FINANCIAL SERVICES INC. (1.5K shares), and Gradient Investments LLC (0 shares).
This table shows the top 4 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.